Quality of life and depression assessment in nevoid basal cell carcinoma syndrome

Maulik Shah, Melissa Mavers, Alanna Bree, Scott Fosko, Nathan H. Lents

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background Nevoid basal cell carcinoma syndrome (NBCCS) is a rare genetic disease which causes a variety of dermatological lesions, especially basal cell carcinomas (BCCs), often on the face, neck, and head. Methods Persons attending a national NBCCS support group meeting were asked to participate in survey-based assessments of quality of life and depressive symptoms. Inclusion criteria required a self-reported NBCCS diagnosis, voluntary agreement to participate, and age over 18years. Exclusion criteria included cognitive impairment. Skin-related quality of life was assessed with Skindex-29, completed by 32 participants. Depressive symptomatology was determined with the Center for Epidemiological Studies Depression Scale (CES-D), completed by 18 participants. Sociodemographic, medical, and social variables were also analyzed. Results Median Skindex-29 scores for the emotions, symptoms, and functioning scales were 42.50, 32.14, and 28.13, respectively (means: 41.17, 37.05, and 29.30, respectively). These scores were slightly higher than those observed in patients with neurofibromatosis type1, a similar genetic disease with skin symptoms. The CES-D scores (median=15.50, mean=17.50) suggested that 50% of participants had significant depressive symptomatology. Variables showing moderate associations with the scores included diet, number of affected family members, and treatment type. Interestingly, the number of BCCs had no effect. Conclusions Nevoid basal cell carcinoma syndrome impacts the quality of life of its subjects in a similar manner to other genodermatoses. Depressive symptoms are particularly prevalent. Several demographic, medical, and social characteristics affect these outcomes. Thus, the psychological impact of this disorder should be evaluated in the course of considering the care of persons with NBCCS.

Original languageEnglish (US)
Pages (from-to)268-276
Number of pages9
JournalInternational Journal of Dermatology
Volume50
Issue number3
DOIs
StatePublished - Mar 1 2011
Externally publishedYes

Fingerprint

Basal Cell Nevus Syndrome
Quality of Life
Depression
Basal Cell Carcinoma
Genetic Skin Diseases
Epidemiologic Studies
Inborn Genetic Diseases
Neurofibromatoses
Group Processes
Self-Help Groups
Rare Diseases
Emotions
Neck
Head
Demography
Psychology
Diet
Skin

ASJC Scopus subject areas

  • Dermatology

Cite this

Quality of life and depression assessment in nevoid basal cell carcinoma syndrome. / Shah, Maulik; Mavers, Melissa; Bree, Alanna; Fosko, Scott; Lents, Nathan H.

In: International Journal of Dermatology, Vol. 50, No. 3, 01.03.2011, p. 268-276.

Research output: Contribution to journalArticle

Shah, Maulik ; Mavers, Melissa ; Bree, Alanna ; Fosko, Scott ; Lents, Nathan H. / Quality of life and depression assessment in nevoid basal cell carcinoma syndrome. In: International Journal of Dermatology. 2011 ; Vol. 50, No. 3. pp. 268-276.
@article{9cf0e39602b84f93a165255c07e62093,
title = "Quality of life and depression assessment in nevoid basal cell carcinoma syndrome",
abstract = "Background Nevoid basal cell carcinoma syndrome (NBCCS) is a rare genetic disease which causes a variety of dermatological lesions, especially basal cell carcinomas (BCCs), often on the face, neck, and head. Methods Persons attending a national NBCCS support group meeting were asked to participate in survey-based assessments of quality of life and depressive symptoms. Inclusion criteria required a self-reported NBCCS diagnosis, voluntary agreement to participate, and age over 18years. Exclusion criteria included cognitive impairment. Skin-related quality of life was assessed with Skindex-29, completed by 32 participants. Depressive symptomatology was determined with the Center for Epidemiological Studies Depression Scale (CES-D), completed by 18 participants. Sociodemographic, medical, and social variables were also analyzed. Results Median Skindex-29 scores for the emotions, symptoms, and functioning scales were 42.50, 32.14, and 28.13, respectively (means: 41.17, 37.05, and 29.30, respectively). These scores were slightly higher than those observed in patients with neurofibromatosis type1, a similar genetic disease with skin symptoms. The CES-D scores (median=15.50, mean=17.50) suggested that 50{\%} of participants had significant depressive symptomatology. Variables showing moderate associations with the scores included diet, number of affected family members, and treatment type. Interestingly, the number of BCCs had no effect. Conclusions Nevoid basal cell carcinoma syndrome impacts the quality of life of its subjects in a similar manner to other genodermatoses. Depressive symptoms are particularly prevalent. Several demographic, medical, and social characteristics affect these outcomes. Thus, the psychological impact of this disorder should be evaluated in the course of considering the care of persons with NBCCS.",
author = "Maulik Shah and Melissa Mavers and Alanna Bree and Scott Fosko and Lents, {Nathan H.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1111/j.1365-4632.2010.04658.x",
language = "English (US)",
volume = "50",
pages = "268--276",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Quality of life and depression assessment in nevoid basal cell carcinoma syndrome

AU - Shah, Maulik

AU - Mavers, Melissa

AU - Bree, Alanna

AU - Fosko, Scott

AU - Lents, Nathan H.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Background Nevoid basal cell carcinoma syndrome (NBCCS) is a rare genetic disease which causes a variety of dermatological lesions, especially basal cell carcinomas (BCCs), often on the face, neck, and head. Methods Persons attending a national NBCCS support group meeting were asked to participate in survey-based assessments of quality of life and depressive symptoms. Inclusion criteria required a self-reported NBCCS diagnosis, voluntary agreement to participate, and age over 18years. Exclusion criteria included cognitive impairment. Skin-related quality of life was assessed with Skindex-29, completed by 32 participants. Depressive symptomatology was determined with the Center for Epidemiological Studies Depression Scale (CES-D), completed by 18 participants. Sociodemographic, medical, and social variables were also analyzed. Results Median Skindex-29 scores for the emotions, symptoms, and functioning scales were 42.50, 32.14, and 28.13, respectively (means: 41.17, 37.05, and 29.30, respectively). These scores were slightly higher than those observed in patients with neurofibromatosis type1, a similar genetic disease with skin symptoms. The CES-D scores (median=15.50, mean=17.50) suggested that 50% of participants had significant depressive symptomatology. Variables showing moderate associations with the scores included diet, number of affected family members, and treatment type. Interestingly, the number of BCCs had no effect. Conclusions Nevoid basal cell carcinoma syndrome impacts the quality of life of its subjects in a similar manner to other genodermatoses. Depressive symptoms are particularly prevalent. Several demographic, medical, and social characteristics affect these outcomes. Thus, the psychological impact of this disorder should be evaluated in the course of considering the care of persons with NBCCS.

AB - Background Nevoid basal cell carcinoma syndrome (NBCCS) is a rare genetic disease which causes a variety of dermatological lesions, especially basal cell carcinomas (BCCs), often on the face, neck, and head. Methods Persons attending a national NBCCS support group meeting were asked to participate in survey-based assessments of quality of life and depressive symptoms. Inclusion criteria required a self-reported NBCCS diagnosis, voluntary agreement to participate, and age over 18years. Exclusion criteria included cognitive impairment. Skin-related quality of life was assessed with Skindex-29, completed by 32 participants. Depressive symptomatology was determined with the Center for Epidemiological Studies Depression Scale (CES-D), completed by 18 participants. Sociodemographic, medical, and social variables were also analyzed. Results Median Skindex-29 scores for the emotions, symptoms, and functioning scales were 42.50, 32.14, and 28.13, respectively (means: 41.17, 37.05, and 29.30, respectively). These scores were slightly higher than those observed in patients with neurofibromatosis type1, a similar genetic disease with skin symptoms. The CES-D scores (median=15.50, mean=17.50) suggested that 50% of participants had significant depressive symptomatology. Variables showing moderate associations with the scores included diet, number of affected family members, and treatment type. Interestingly, the number of BCCs had no effect. Conclusions Nevoid basal cell carcinoma syndrome impacts the quality of life of its subjects in a similar manner to other genodermatoses. Depressive symptoms are particularly prevalent. Several demographic, medical, and social characteristics affect these outcomes. Thus, the psychological impact of this disorder should be evaluated in the course of considering the care of persons with NBCCS.

UR - http://www.scopus.com/inward/record.url?scp=79951929140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951929140&partnerID=8YFLogxK

U2 - 10.1111/j.1365-4632.2010.04658.x

DO - 10.1111/j.1365-4632.2010.04658.x

M3 - Article

C2 - 21342158

AN - SCOPUS:79951929140

VL - 50

SP - 268

EP - 276

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 3

ER -